Product Images Lisdexamfetamine Dimesylate

Interacting drug: Guanfacine, Venlafaxine CYP1A2 Substrates: Caffeine CYP2D6 Substrates: Dextromethorphan CYP2C19 Substrates: Omeprazole CYP3A Substrates: Midazolam PK parameters: Cmax and AUC Fold Change and 90% confidence interval (CI): - The fold change for the interaction is 0.0 - T T T indicates no significant change relative to the reference - The change relative to reference is 20%*

The given text appears to be a table showing LS Mean (SE) SKAMP Deportment Scores for a study involving a placebo and lisdexamfetamine dimesylate capsules. The table includes scores at different time points post-dose. However, the specific information regarding the scores and their interpretation is not available.*

Each capsule contains 20 mg of Lisdexamfetamine dimesylate, which is equivalent to 11.6 mg of lisdexamfetamine. The recommended storage temperature is between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The medication is defined in the USP. It is manufactured by Prinston Laboratories in Charlotte, NC and distributed by Solco Healthcare US LLC in Somerset, NJ. The package insert should be referred to for dosage information.*

Each capsule contains 30 mg of Lisdexamfetamine dimesylate, which is equivalent to 17.3 mg of lisdexamfetamine. This medication should be stored at room temperature, between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). It is important to consult the package insert for specific dosage information. The medication is defined in the USP and is distributed by Solco Healthcare US, LLC, based in Somerset, NJ, USA. The manufacturer of the medication is Prinston Laboratories located in Charlotte, NC, USA. Unfortunately, no additional information is available from the provided text.*

This text is a description of a medication called Lisdexamfetamine dimesylate. Each capsule contains 50 mg of the medication, which is equivalent to 28.9 mg of lisdexamfetamine. The recommended storage temperature is between 20°C and 25°C (68°F to 77°F). The medication is defined in the USP. Additional information, such as dosage instructions and distribution details, can be found in the package insert.*

Not available.*

This text is a package insert for a medication called Lisdexamfetamine dimesylate. Each capsule contains 70 mg of the active ingredient, which is equivalent to 40.5 mg of lisdexamfetamine. The recommended dosage information is provided in the package insert. The medication should be stored at room temperature, between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). The medication is manufactured by Prinston Laboratories in Charlotte, USA, and distributed by Solco Healthcare USLLC in Somerset, USA. The insert mentions a separate medication guide provided to each patient. Unfortunately, the remaining part of the text is not legible.*